Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Consulate General of the
Argentine Republic in Sydney
Perfil de Mercado
INDUSTRIA FARMACEUTICA en
Australia
Sección Comercial Consulado General de la Republica Argentina en Sydney – Australia
Diciembre 2010
INDICE
INTRODUCCION 1- Finalidad del estudio 2- Posición arancelaria y descripción del producto PRIMERA PARTE – EL MERCADO DE LA INDUSTRIA FARMACEUTICA EN AUSTRALIA 3- Situación actual 3.1 Sector externo y tarifas 3.2 Política regional australiana y acuerdos de libre comercio SEGUNDA PARTE – COSTOS Y DOCUMENTACION GENERAL 4- Costo de nacionalización 4.1 Aranceles de importación Apéndice I – Tratamiento arancelario australiano 4.2 Impuestos locales y aranceles 4.3 Despacho aduanero y documentos exigidos por Aduana 4.4 Costo de apertura de carta de crédito 5- Requisitos sanitarios 6- Standards y otros requisitos técnicos TERCERA PARTE – EVOLUCION DE LAS IMPORTACIONES 7-Cifras de importación 2009 Apéndice II – Evolución de las importaciones australianas de productos Farmacéuticos 2009 8. Participación de Argentina Apéndice III – Evolución y participación de la Argentina 9-Niveles de precios 10-Canales de comercialización 11-Principales centros de consumo 12-Embalaje y formas de etiquetado 12.1 Transporte CUARTA PARTE – ACCESO AL MERCADO AUSTRALIANO 13-Ingresar al mercado australiano 14-Zonas Francas 15-Ferias y exposiciones generales y especializadas 16-Asociaciones sectoriales 17-Publicaciones y sitios de interés 18-Listado de importadores
INTRODUCCION
1. FINALIDAD DEL ESTUDIO
El presente perfil de mercado, ha sido realizado por la Sección Comercial del Consulado General de la Republica Argentina en Sydney, Australia, conforme la metodología del “Manual de Promoción Comercial”, Subsecretaria de Relaciones Comerciales Internacionales, 2010. Trata de productos farmacéuticos y terapéuticos, bioquímica, genética, biología molecular, inmunológica, biología celular; dispositivos biomédicos tales como: aparatos de asistencia ventricular, aparatos de audición, prótesis de cadera y rodilla, mercado genético, toxinas y alimentos; plataformas tecnológicas tales como bioinformática, tecnologías de separación, biosensores y nano tecnología; Medicina Complementaria. Pretende facilitar información actualizada a fabricantes, exportadores argentinos y cámaras del sector, sobre el mercado de la Industria Farmacéutica Australiana. Este perfil de mercado informa acerca de algunos aspectos de la economía y de la política comercial externa australiana que puede afectar la comercialización de estos productos, quienes son y donde se encuentran los importadores de productos farmaceuticos en Australia. Asimismo, intentará señalar las modalidades de comercialización, sea que los agentes económicos interesados exporten en forma directa o indirecta y la relación logística central del comercio entre Argentina y Australia de productos farmaceuticos: volumen – flete.
2. POSICIONES ARANCELARIAS Y DESCRIPCION DE PRODUCTOS Nomenclatura comun MERCOSUR (N.C.M) 30.01 Glándulas y demás órganos para usos opoterápicos, desecados, incluso pulverizados; extractos de glándulas o de otros órganos o de sus secreciones, para usos opoterápicos; heparina y sus sales; las demás sustancias humanas o animales preparadas para uso terapéuticos o profilácticos, no expresadas ni comprendida en otra parte. 30.02 Sangre humana; sangre animal preparada para usos terapéuticos, profilácticos o de diagnostico; sueros especificados de animales o de personas inmunizados y demás componentes de la sangre; vacunas, toxinas, cultivos de microorganismos (con exclusión de las levaduras) y productos similares. 30.03 Medicamentos (con exclusión de los productos de las partidas 30.02, 30.05 o 30.06) constituidos por productos mezclados entre si preparados para usos terapéuticos o profilácticos, sin dosificar ni acondicionar para la venta al por menor. 30.04 Medicamentos (con exclusión de los productos de las partidas 30.02, 30.05 o 30.06) constituidos por productos mezclados o sin mezclar, preparados para usos terapéuticos o profilácticos, dosificados o acondicionados para la venta al por menor 30.05 Guatas, gasas, vendas y artículos análogos (por ejemplo: apositos, esparadrapos, sinapismos), impregnados o recubiertos de sustancias farmacéuticas o acondicionados para la venta al por menor con fines médicos, quirúrgicos, odontológicos o veterinarios. 30.06 Preparaciones y artículos farmacéuticos a que se refiere la nota 3 del capitulo.
PRIMERA PARTE – EL MERCADO DE LA INDUSTRIA FARMACEUTICA EN AUSTRALIA
3 – SITUACION ACTUAL La Industria Farmacéutica Australiana comprende un 1% del mercado farmacéutico mundial, con una facturación de U$S 14.200 millones. En su totalidad la Industria emplea unas 34.000 personas, a través de por lo menos 300 firmas e Instituciones, incluyendo manufacturación, investigación y ventas. Las exportaciones Australianas de la Industria farmacéutica han crecido de un poco mas de U$S 84 millones en 1985, a U$S 3.255 millones en 2007, convirtiéndose en una de las industrias líderes en volumen de exportación. La industria farmacéutica Australiana invierte en promedio U$S 625 millones en investigación y desarrollo. En total la industria farmacéutica mundial invierte unos U$S 45.000 millones en análisis y desarrollo, mostrando la tendencia al crecimiento de la industria mediante el descubrimiento de nuevos medicamentos. El costo promedio del desarrollo de un nuevo medicamento es de U$S 1.000 millones, y el tiempo que lleva en desarrollarla es de 12 a 15 años. Solo 5 de cada 10.000 compuestos investigados son testeados en pruebas clínicas. De esos 5 solo 1 es aprobado como apto para uso público. En promedio, solo 3 de cada 10 medicamentos desarrollados lograrán cubrir sus costos de elaboración totales (incluyendo análisis y desarrollo, pruebas clínicas, marketing, entre otros). Al ser los costos de análisis y desarrollo tan altos, las patentes y propiedades intelectuales se han convertido en un problema mayor para los integrantes de la Industria Farmacéutica. Las compañías farmacéuticas están continuamente trabajando en desarrollar drogas más efectivas para el tratamiento de distintas enfermedades. En el mundo hay más de 1.000 medicamentos nuevos a prueba para Mal de Alzheimer, Infarto, Fibrosis Quistica, Artritis y muchas otras enfermedades. Existen casi 400 medicamentos a prueba como tratamiento para el cáncer. En esta última década, más de 300 medicamentos fueron creados para tratar distintas enfermedades. Entre los cambios estructurales podemos resaltar falta de productividad en las lineas de produccion de medicamentos, vencimiento de patentes protegiendo drogas de gran potencial comercial y una declinación del retorno financiero de inversiones en analisis y desarrollo. 3.1 Sector externo y tarifas La industria de Salud y Medicina Australiana es conocida globalmente por su innovación, diversidad, tecnología, capacidad, análisis y desarrollo, y por su robusto sistema de Salud. La Industria Tecnológica Médica Australiana tuvo un ingreso anual de U$S 3.990 millones en 2006-2007. En el 2006 las exportaciones de la misma tenían un valor de aproximadamente U$S 1.092, y U$S 2.436 millones como valor de las importaciones para el mismo año. Dichas cifras nos muestran la sólida tendencia al comercio internacional de la Industria Médica y Farmacéutica, exportando aproximadamente el 87% de la producción local de la misma. La industria de maquinaria médica esta caracterizada por un pequeño número de compañías multinacionales (alrededor del 20% de la industria), y un gran número de pequeñas y medianas empresas (un 80% de la industria). Algunas de las empresas productoras de medicamentos Australianas son líderes mundiales. Entre ellas se encuentran ResMed y Cochlear. Según “IBIS World” la Industria de producción Médica y de Equipamiento Quirúrgico Australiana comprende aproximadamente 2.900 establecimientos y 10.320 empleados en 2007-2008. La Industria de Maquinaría Médica mundial tiene un valor estimado de U$S 146.160 millones, de este total Australia representa un 0,6%.
3.2 Política regional Australiana y acuerdos de libre comercio. Australia es uno de los iniciadores del APEC (Asia Pacific Economic Cooperation) cuyo punto más alto se alcanzo en 1994 cuando sus miembros acordaron un cronograma para la liberalización del comercio. Como consecuencia una de las prioridades de la política comercial externa reciente de Australia ha sido la negociación de Acuerdos Bilaterales de Comercio. En adición al acuerdo con Nueva Zelanda “Australian – New Zealand Closer Economic Relations Trade Agreemen” (ANZCERTA), Australia ha firmado otros acuerdos bilaterales de comercio (preferenciales): con Singapur (SAFTA); con Tailandia (TAFTA) y con los Estados Unidos, “Australia – United Status Free Trade Agreement” (AUSFTA), y esta negociando acuerdos preferenciales con China, Malasia, Chile, Países del Golfo, Japón y Corea. La firma del AUSFTA ha generado modificaciones en reglas de origen y propiedad intelectual (“Copyright Act 1968” y “Patents Act 1990”). Las preferencias otorgadas por Australia en el marco de los acuerdos firmados erosionan las otorgadas a los Países Menos Adelantados (LDC) y a los Países (o economías) en desarrollo dentro del Sistema Generalizado de Preferencias de UNCTAD (SGP).
SEGUNDA PARTE – COSTOS Y DOCUMENTACION GENERAL
4- COSTOS DE NACIONALIZACION 4.1. Aranceles de Importación Los aranceles aplicados por Australia a las posiciones de productos farmacéuticos pueden consultarse en el Apéndice I. La mayoría de las tarifas que afectan a las posiciones arancelarias descriptas en el punto 2, se ubican entre el 5% y el 7%. Australia aplica preferencias arancelarias y acceso libre a bienes originarios de 50 Países Menos Adelantados (LDC), Papua Nueva Guinea, Nueva Zelanda y Singapur, y preferencias tarifarías a 90 países (o economías) en desarrollo dentro del Sistema Generalizado de Preferencias de UNCTAD (SGP), algunas de las cuales benefician a la Argentina como PED. 4.2 Impuestos locales y aranceles. Además de los aranceles, las importaciones están sujetas al impuesto sobre bienes y servicios, “Goods and Services Tax o GST” (Equivalente al IVA). El GST se aplica desde el 1 de Julio del 2000, a la mayoría de los bienes locales e importados, y es el 10% sobre la base imponible de importación (valué of tasable import o VOT) en el caso de importados, formada por la suma de su valor de factura, más arancel exigible, mas el transporte o flete y el seguro. Un número limitado de bienes están exentos del GST: ciertos alimentos, salud, educación, guarderías, alquiler de viviendas y servicios financieros. Con respecto al valor en aduana debe considerarse que Australia es signataria del acuerdo de Valoración en Aduana GATT/OMC desde 1981. El órgano de aplicación es la oficina de impuestos equivalente a la AFIP en Argentina, o Australian Taxation Office, cuyo sitio Web para mayor información es www.ato.gov.au . Información adicional puede obtenerse asimismo a través de la aduana australiana, Australian Customs Service, www.customs.gov.au . 4.3. Despacho aduanero y documentos exigidos por la Aduana Australiana La declaración de aduanas es regida en Australia por el Customs Act de 1901. En octubre del 2005 se estableció el denominado “Integrated Cargo System” (ICS) para las importaciones que llegan a los terminales australianos. Los clientes o importadores “per se”, o a través de sus despachantes de aduana, deben registrarse en la Aduana Australiana (Australian Customs Services). El 99 % de los despachos se procesan electrónicamente.
Las declaraciones de importación dentro del sistema integrado de carga, (o sus embalajes) sujetas a restricciones de cuarentena, deben respetar los requerimientos tanto de la Aduana Australiana (ACS) como del Servicio de Inspección de Cuarentena Australiano (Australian Quarantine Inspection Service, AQUIS) Los principales documentos exigidos por el “Australian Custom Service” son: la factura comercial; el conocimiento de embarque; el certificado de cuarentena (si aplica); la lista de empaque (packing list). Puede eventualmente exigirse el documento de seguro (opcional) si el embarque es CIF. Los costos de depósito en muelle o aeropuerto en caso de demoras por problemas documentarios son altos en Australia, así como el transporte, la manipulación de la mercadería, depósito fiscales transcurrido el corto período gratuito de estiba en terminales, por lo cual conviene utilizar los servicios de un despachante de aduana local calificado (custom clearance agent) quien debe ser consultado con antelación para despachar la mercadería en forma inmediata y evitar así mayores costos. Los honorarios profesionales de un Despachante de Aduana en Australia, para el manejo de documentación y la gestión del ingreso de la mercadería en su territorio aduanero, parten de un valor medio de 200 AUD pudiendo llegar a 1000 AUD o más dependiendo de las dificultades. Deben preverse otras cargas o servicios en puerto (handling charges) los que podrían llegar a un estimativo entre un 3 o 4 % de su valor CIF (Fuente: Hellman Worldwide Logistics – NSW – Australia). Para mayor información http://www.customs.gov.au/site/page.cfm?u=4226 4.4. Costo de apertura de carta de crédito Existen muchas posibilidades. En caso de utilizarse una carta de crédito irrevocable (L/C), a la vista y a 30, 60, 90 días, proveedores que puedan ofrecer alternativas de pago superiores, 120 /180 días, seguramente tendrán mayores posibilidades. Según fuente consultada el costo sería de aproximadamente 170 AUD mas el 0.3 % sobre el valor CIF (sin precisar si otros costos podrían estar presentes. La carta de crédito es una modalidad que protege principalmente al exportador cuando no hay experiencia comercial suficiente. Cuando hay un conocimiento mayor pueden utilizarse las transferencias bancarias. 5. REQUISITOS SANITARIOS Leyes, regulaciones y sistemas que rigen el producto importado. Australia aplica estrictas medidas sanitarias y fitosanitarias al ingreso de productos, incluyendo el “import risk análisis” que puede afectar al producto y embalaje. En particular aplica un sistema de cuarentena estricto destinado a proteger su sector Farmacéutico. Cabe tomar en cuenta que todo producto de madera o vegetal que pueda utilizarse para el embalaje de los productos farmacéuticos puede esta sujeto a inspecciones de cuarentena, por lo cual si el servicio de cuarentena lo considera necesario, dispone su fumigación previa al embarque en contenedor o destrucción en aduana, servicio que debe pagar el importador. Es aconsejable que los detalles sean consultados previamente por los respectivos despachantes de aduana intervinientes en el embarque, y que el contenedor sea sometido a fumigación bajo respectivo certificado. 6. STANDARDS Y OTROS REQUISITOS TECNICOS El marco institucional de las normas y estándares en Australia comprende cuatro cuerpos: “Standards Australia” organización que formula los estándares; la “Nacional Association of Testing Authorities” (NATA); el “Joint Accreditation System of Australia and New Zealand” (JAS-ANZ) y el “Nacional Measurement Institute” (NMI) establecido en julio de 2004 para integrar la metrología en física, química y biología.
Australia tiene dos tipos de estándares: voluntarios y regulatorios. La mayoría de los voluntarios son desarrollados y publicados por “Standards Australia”. Otros órganos privados operan en sectores específicos. En el caso de los productos Farmacéuticos deben seguirse ciertos estándares que pueden afectar la seguridad de los operadores. Conviene asimismo tener en cuenta el “Terapéutica Goods Administración (TGA), Guidance on the GMP clearance of oversease medicine manufacturers” (2008) sobre requerimientos de medicamentos www.tga.gov.au/manuf/gmpsom.htm .
TERCERA PARTE – EVOLUCION DE LAS IMPORTACIONES 7. Cifras de Importaciones de productos Farmacéuticos Con respecto a la importación Australiana de productos Farmacéuticos en el año 2009 cabe referirse al Apéndice II, Evolución de las Importaciones Australianas de productos Farmacéuticos 2009 que se incluye como anexo. 7.1. Participación de los países proveedores en las importaciones Los principales proveedores de productos farmacéuticos son Irlanda, Reino Unido, Estados Unidos, Suiza, España y Francia. Mayores precisiones pueden recabarse en el Apéndice II, relativas a cifras según proveedores. 8. Participación de Argentina Las importaciones de origen Argentino totalizaron 1.942.255 USD en el año 2009 conforme detalle Apéndice III. 9. Niveles de Precios de Productos Farmacéuticos
Producto Costo en AUD Fuente
Antiseptic Hand Sanitizer (100/bx)
$15,95 CFA Medical
BACROBIAL Ag™ Foaming Body Cleanser 8oz
$23,95 CFA Medical
Mygrex (MIGRAINE
HEADACHES) 150 X 2
$32.95 CFA Medical
Mouth Kote 8 oz $15,00 Parnell
Pharmaceuticals Anti-Fungal Cream
(Compare to Tinactine®)
144/Box
$16,95 CFA Medical
Ivarest® Cream (Poison Oak & Ivy)
100/Pack $27,95 CFA Medical
Pretz Concentrate $19,95 Parnell
Pharmaceuticals First Aid Burn
Cream (144/box) $14,95 CFA Medical
Actoset Forte 500/Box
$24,95 CFA Medical
Cough Drops Cherry (Compare to
Halls®) 50/Box $3,30 CFA Medical
Vitamin A & D Ointment Unit Dose
144/box $13,95 CFA Medical
Antacid (Compare
to Tums®) 500/Box
$15,95 CFA Medical
10 – CANALES DE COMERCIALIZACION Los productos Farmacéuticos son comercializados en Australia por importadores, mayoristas e importadores/productores. Ver punto 18, listado de importadores. Las ferias de productos Farmacéuticos y afines en Australia son buenos indicadores de la tendencia del mercado. Ver punto 16. Ferias y Exposiciones generales y especializadas. 11. PRINCIPALES CENTROS DE CONSUMO. Este extenso país tiene la mayoría de su población concentrada en la costa este y sudeste. Sus principales centros de consumo son: Sydney (7.191.500 habitantes); Melbourne (5.496.400 habitantes); Brisbane (4.473.000 habitantes); Perth (2.270.300 habitantes); Adelaida (1.633.900 habitantes) y Canberra (354.900 habitantes). Los principales puertos y terminales de Australia son: Brisbane, Dampier, Fremantle, Gladstone, Hay Pint, Melbourne, Newcastle, Port Hedland, Port Kembla, Port Walcott y Sydney. Las mayores terminales de carga aérea en Australia son el aeropuerto de Sydney, Melbourne y Brisbane. 12. EMBALAJES Y FORMAS DE ETIQUETADO Conviene prestar atención al material de embalaje utilizado, previo a la exportación, por el riguroso tratamiento fitosanitario de Australia a los productos que ingresan a su territorio aduanero. Por ejemplo en el caso de la madera, podría requerir la autorización del “Australian Quarantine and Inspection Service” (AQIS). Conviene asimismo, consultar previamente lo relativo a las normas de ingreso a través del propio importador, el despachante de aduana o el Consulado General de la Republica Argentina en Sydney, puesto que los costos de despacho y las demoras son altos en mercado. Las regulaciones australianas exigen en el caso de la importación de productos farmacéuticos y afines, la inscripción en idioma inglés, el país de origen, el tipo de producto del que se trata con su marca y logo, y una descripción de su contenido, peso y cantidad. Sin estas especificaciones podrían surgir problemas con el despacho a plaza por el “Australian Customs Service”. Para mayor información usted podrá consultar en mayor detalle requerimientos de etiquetado y embalaje enviando su consulta a [email protected] . 12.1 Transporte La ecuación volumen – precio es estratégica en el comercio de productos farmacéuticos entre Argentina y Australia, los embarques pueden realizarse desde Argentina por via marítima (45 días) via Singapur por ejemplo – como uno de los puertos posibles. La via aérea es un medio de mayor rapidez y costo. Pueden utilizarse las dos líneas aéreas directas a Australia via Santiago de Chile – Auckland –Sydney a la fecha de realización de este informe, o una alternativa es el courier aéreo misma via o por Estados Unidos.
CUARTA PARTE – ACCESO AL MERCADO AUSTRALIANO
13. Ingresar al Mercado Australiano El contacto directo con el importador por correo electrónico u otro medio, debe realizarse por medio de un texto rigurosamente preparado en inglés, y material ilustrativo de calidad también en inglés. De hecho serán las ilustraciones, o un folleto electrónico realizado por un profesional y no la cámara personal sobre una mesa de la fábrica la que podrá abrir la posibilidad comercial en Australia.
El contacto deberá completarse con el envío de un catálogo en inglés, su impresión profesional conviene que sea igual o mejor al producido localmente por las empresas comercializadoras del sector. Es imprescindible un sitio Web bilingüe, de buen diseño, con información acerca de la compañía, dirección, teléfonos, email y fax. En Australia es esencial el contacto personalizado y un seguimiento adecuado. 14. Zonas Francas La única zona franca existente en Australia fue creada en Septiembre de 1985 y es conocida como “Trade Development Zone” (TDZ). Esta situada en Darwin, capital del Territorio Norte, la zona menos desarrollada del país, y la más cercana al Sudeste Asiático. Es una zona especial de procesamiento industrial operada por la “Trade Development Authority”, orientada a la exportación. Las Industrias establecidas en dicha zona incluyen textiles, cartón y embalaje, representaciones gráficas en color, desarrollo de software, cerveza, emulsión de pescado, plantas de alimentos, inyección de plásticos y otros productos industriales. Cabe decir asimismo que el puerto de Brisbane, en Queensland, ha eliminado ciertas cargas por lo que su puerto opera, tomando como referencia el embarque marítimo, un veinte por ciento (20%) mas barato que Sydney y, un treinta y seis por ciento (-36%) menos que el de Melbourne. 15. Ferias y Exposiciones Generales y Especializadas 1- The Natural Health Conference and Expo PO Box 55 Glebe NSW 2037 Phone: 1300 789 845 Fax: 02 9660 9786 Email: [email protected] 2- Natural Healthcare Expo, Sydney. Natural Therapy Pages Level 3 46 - 56 Kippax St Surry Hills NSW 2010 Australia 3- Health@Melbourne Expo Janice Powell, Manager, Alumni and Events Advancement and Communications Faculty of Medicine, Dentistry and Health Sciences Phone: +61 3 8344 8058 Fax: +61 3 9347 8939 Email: [email protected] 4- Smiggins Ski Conference SMA Queensland Branch Suite 2.04 Sports House 150 Caxton St MILTON, QLD 4064 Phone:(07) 3367 2700 or 1800 007 501 (Regional) Fax: (07) 3367 2800 Email: [email protected]
5- ACSMS 2010 Jueves 4 de Noviembre 2010, Sheraton Mirage Resort Davina Sanders, Conference Manager Ph: 02 6241 9344 email [email protected] 6- STC 2010 Sabado, 13 Nov 2010 Sports House 375 Albert Road SOUTH MELBOURNE VIC 3205 Phone: (03) 9674 8777 Fax: (03) 9674 8799 [email protected] www.vic.sma.org.au 7- VIC Nursing and Health Expo 18 April 2010. Street Address: 1 Napier Close DEAKIN WEST ACT 2600 Postal Address: PO Box 219 DEAKIN WEST ACT 2600
16. Asociaciones Sectoriales
A- Australian Pharmaceutical Industries (API)
11 Grand Avenue Camellia, NSW 2142 Australia Phone: (02) 8844 2000 Fax: (02) 8844 2896Mailing Address: Locked Bag 5061 Parramatta, NSW 2124 Australia
B- Medicines Australia Level 1 16 Napier Close Deakin ACT 2600 Phone 02 6122 8500 Fax 02 6122 8555 Email [email protected] C- GS1 Australia Sydney Lakes Business Park, Building 4B, 2-4 Lord Street, Botany NSW 2019 Locked Bag 7002, Botany NSW 1455 Switch: 02 9700 0933 Fax: 02 9700 0820 D- ARCS Australia Ltd Suite 802, 28 Clarke Street CROWS NEST NSW 2065 Ph: 02 8905 0829 Fax: 02 8905 0830 Email: [email protected] Web: www.arcs.com.au
E- TGA – Therapeutic Goods Administration. TGA, PO Box 100, Woden ACT 2606, Australia Email: [email protected] Web: www.tga.gov.au F- Australian Doctor Fund. PO Box 12, Arncliffe NSW 2205 Telephone: 02 9567 5595 Facsimile: 02 9567 4050 Web: www.adf.com.au G- Nanostructural Analysis Network Organisation (NANO) Website: www.nano.org.au Contact: Dr Miles Apperley Phone: +61 2 9351 2887 Fax: +61 2 9351 7682 Email: [email protected] Address: Madsen Building (F09) The University Of Sydney NSW Australia 2006 H - National Health and Medical Research Council Clinical Trials Centre Website: www.ctc.usyd.edu.au Contact: Prof John Simes Phone: +61 2 9562 5000 Fax: +61 2 9565 1863 Email: [email protected] Address: Level 5, Building F 88 Mallett St Camperdown NSW Australia 2050 I - National Hearing Aid Systems Pty Ltd Contact: Mr Teck Loi Phone: +61 2 9413 2588 Fax: +61 2 9411 2950 Address: 126 Greville Street Chatswood NSW Australia 2067 J - National Institute of Complementary Medicine Professor Alan Bensoussan Executive Director Phone: +61 2 4620 3709 Email: [email protected] Website: www.nicm.edu.au K - National Measurement Institute Phone: +61 2 9449 0141 Fax: +61 2 9449 1653 Email: [email protected] Website: www.measurement.gov.au L- NeuClone Pty Ltd Phone: +612 9345 6992 Fax: +612 9661 3992 Email: [email protected] Website: www.neuclone.com
M - NeuMedix Health Group Phone: +61 2 9957 4796 Fax: +61 2 9957 4713 Email: [email protected] Address: Level 6 1 Elizabeth Plaza North Sydney NSW Australia 2060 N - Newcastle Bone and Joint Centre Website: www.newcastle.edu.au/faculty/health/resear Contact: Dr Nikolai Bogduk Phone: +61 2 4922 3505 Fax: +61 2 4922 3559 Email: [email protected] Address: Department of Clinical Research Newcastle Bone & Joint Centre Newcastle NSW Australia 2300 O – Australian Medical Association (AMA) Phone: 02 6270 5400 Fax: 02 6270 5499 Email: [email protected] Website: www.ama.com.au Postal Address: PO Box 6090 KINGSTON ACT 2604 Street Address: 42 Macquarie Street BARTON ACT 2600 17. Publicaciones y Sitios de Interes A- Australian Doctor http://www.australiandoctor.com.au B- Medical Observer www.medicalobserver.com.au C – Medical Hub www.medicalhub.com.au D – Nursing Post Magazine www.nursingpost.com.au E – Australian Journal of Medical Science B2B Magazines - Medicine & Healthcare Phone: 07 3876 2988 Web: www.aims.org.au 18. Listado de Importadores
Sanofi Aventis Group
Ref.No: 015764
ACN: 057 960 255
Email, Importer, Website
Subtitle: Division of Sterling Pharmaceuticals Pty Ltd - NSW Activity Group: Manufacturing;
Ascot Pharmaceuticals Proprietary Limited
Ref.No: 053022
ACN: 000 291 967
ABN: 44 000 291 967
Physical Address: Postal Address: 16 Byfield St
North Ryde NSW 2113 Australia
Locked Bag 2227 North Ryde BC NSW 1670
Australia
Phone: 61 2 8899 0700 Fax: 61 2 8899 0600
Freecall: 1800 818806
Email: [email protected]
Website: http://www.sanofi-synthelabo.com.au
Product Summary: Pharmaceuticals Year Established: 1994
Number of employees: 120
Annual turnover: $45,000,000
Bank: BNP Paribas Equities Australia Ltd Westpac Banking Corporation
Member Of: APMA;
Key Personnel: Medical Director: Victoria Elegant
General Manager: George Petrenas State Manager: Tom Leonard
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 213-233 Elizabeth St
CROYDON NSW 2132 Australia
P O Box 79 Croydon NSW 2132
Australia
Phone: 61 2 9798 9066 Fax: 61 2 9799 8948
Product Summary: Pharmaceuticals Year Established: 0
Number of employees: 5
Export Areas / Countries: Fiji, Papua New Guinea
Astra Tech
Ref.No: 105713
ABN: 46 112 267 133
Email, Exporter, Importer, Website
Australian Pharmaceutical Industries Limited
Ref.No: 014699
ACN: 000 004 320
ABN: 57 000 004 320
Website
Subtitle: Astra Tech Pty Ltd
Activity Group: Manufacturing; Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: Unit 1, 53 Grandview St
PYMBLE NSW 2073 Australia
Phone: 61 2 9488 3500 Fax: 61 2 9440 0744
Email: [email protected]
Website: http://www.astratech.com
Product Summary: Medical/surgical devices Year Established: 0
Number of employees: Unknown
Products: 38891 Medical and surgical instruments (cont'd)
- 3889135-DEI - Instruments and catheters for urology and urodynamics 38910 Medical and surgical equipment
- 3891034-DEI - Spectroscopic equipment, medical diagnosis 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade)
67700 Hospital, medical, dentistry and veterinary equipment (trade) - 6770005-DEI - Medical and surgical instruments (trade)
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 11 Grand Ave
ROSEHILL NSW 2142 Australia
Locked Bag 5061 Parramata NSW 2124
Australia
Clear Sales Australia Proprietary Limited
Ref.No: 079549
ABN: 75 061 414 275
Email, Website
Phone: 61 2 8844 2000 Fax: 61 2 8844 2401
Website: http://www.api.com.au
Product Summary: Pharmacy and medical wholesalers Year Established: 1910
Number of employees: 500
Key Personnel: Chairman: Frank Conroy
Deputy Chairman: Barry Frost Sales Manager: David Young
:
Products: 63960 Cosmetics and toiletries (trade)
- 6396004-D - Cosmetics and creams (trade) 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) 66500 Chemical products (trade)
- 6650012-D - Fine chemicals (trade)
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: Unit 1, 22 Hudson Ave,
CASTLE HILL NSW 2154 Australia
Phone: 61 2 9894 8888 Fax: 61 2 9894 8800
Email: [email protected]
Website: http://www.clearsales.com.au
Product Summary: Pharmaceuticals Year Established: 0
Number of employees: 25
Products: 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade) - 6398003-D - Pharmaceutical oils and Vaseline (trade) - 6398017-D - Vitamins, hormones and organ extracts (trade) - 6398018-D - Antiseptics (trade)
Clifford Hallam Healthcare Proprietary Limited
Ref.No: 104924
ABN: 38 001 655 554
Qual. Rated, Website
Clifford Hallam Healthcare Pty Ltd
Ref.No: 058525
ABN: 38 001 655 554
Email, Qual. Rated, Website
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 60 South Park Dr
DANDENONG SOUTH VIC 3175 Australia
Phone: 61 3 9554 0500 Fax: 61 3 9554 0400
Website: http://www.ch2.net.au
Product Summary: Pharmaceuticals and medical consumables Year Established: 0
Number of employees: 50
Products: 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade) - 6398003-D - Pharmaceutical oils and Vaseline (trade) - 6398017-D - Vitamins, hormones and organ extracts (trade) - 6398018-D - Antiseptics (trade)
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 30-34 Eva St
ROSELANDS NSW 2196 Australia
P O Box 565 Riverwood NSW 2210
Australia
Douglas Pharmaceuticals Australia Limited
Ref.No: 058624
ABN: 17 003 854 626
Email, Website
Exportim (SA) Proprietary Limited
Ref.No: 036735
ACN: 007 784 463
Phone: 61 2 9584 4344 Fax: 61 2 9584 4374
Freecall: 1300 720 274
Email: [email protected]
Website: http://www.ch2.net.au
Product Summary: Pharmaceuticals and medical consumables and equipment, Healthcare products and services
Year Established: 1973 Number of employees: 300
Products: 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade) - 6398003-D - Pharmaceutical oils and Vaseline (trade) - 6398017-D - Vitamins, hormones and organ extracts (trade) - 6398018-D - Antiseptics (trade)
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: Unit 3, 10 Inglewood Place Baulkham Hills NSW 2153
Australia
P O Box 7004 Baulkham Hills BC NSW 2153
Australia
Phone: 61 2 8818 2111 Fax: 61 2 8818 2122
Email: [email protected]
Website: http://www.douglas.com.au
Product Summary: Pharmaceuticals Year Established: 1989
Number of employees: 35
Products: 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade)
ABN: 44 007 784 063
Email, Exporter
HPS Pharmacies
Ref.No: 103879
ABN: 38 174 017 938
Email, Website
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 3a Crystal Ave
St Marys SA 5042 Australia
Phone: 61 8 8277 3582 Fax: 61 8 8277 7957
Product Summary: Royal jelly products Year Established: 0
Number of employees: 3
Export Areas / Countries: Europe, South Korea, Middle East, New Zealand
Key Personnel: Director: Effie Elovaris
Products: 63960 Cosmetics and toiletries (trade)
- 6396004-DE - Cosmetics and creams (trade) - 6396010-DE - Soap, toilet (trade) - 6396012-DE - Haircare products (trade)
63980 Pharmaceuticals (trade) - 6398010-DE - Herbal medicines (trade)
Subtitle: HPS SA Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 29 Alexander Ave Ashford SA 5035
Australia
Key Personnel: Partner: Janene Garde Partner: Stephen Furlan Partner: Trevor Draysey Partner: Amanda Francis
Polcopharma F Polley & Co Pty Ltd
Ref.No: 018292
Website
Products: 63980 Pharmaceuticals (trade)
- 6398001-D - Medicines (trade) - 6398002-D - Parapharmaceutical preparations (trade) - 6398003-D - Pharmaceutical oils and Vaseline (trade
Activity Group: Imp/Exp/Dist/Wholesale;
Physical Address: Postal Address: 35 Oxford St
EPPING NSW 2121 Australia
P O Box 100 Epping NSW 2121
Australia
Phone: 61 2 9876 6485 Fax: 61 2 9868 2266
Website: http://www.polcopharma.com.au
Product Summary: Herbal products Number of employees: 10
Key Personnel: Managing Director: Reinhard Polley
Products: 63960 Cosmetics and toiletries (trade)
- 6396004-D - Cosmetics and creams (trade) 63980 Pharmaceuticals (trade)
- 6398010-D - Herbal medicines (trade)
Apéndice I - CUSTOMS TARIFF SCHEDULE 3
Section 6 R.6 Chapter 30/3
Reference Number
Statistical Code/Unit Goods Rate #
3001 GLANDS AND OTHER ORGANS FOR ORGANO-
THERAPEUTIC USES, DRIED, WHETHER OR NOT POWDERED; EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANO-THERAPEUTIC USES; HEPARIN AND ITS SALTS; OTHER HUMAN OR ANIMAL SUBSTANCES PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT ELSEWHERE SPECIFIED OR INCLUDED:
3001.20.00 07 .. - Extracts of glands or other organs or of their
secretions
Free
� � 3001.90.00 - Other Free
05 .. Glands and other organs, dried, whether or not powdered 08 .. Other
3002 HUMAN BLOOD; ANIMAL BLOOD PREPARED
FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA AND OTHER BLOOD FRACTIONS AND MODIFIED IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICRO-ORGANISMS (EXCLUDING YEASTS) AND SIMILAR PRODUCTS:
3002.10.00 23 .. - Antisera and other blood fractions and modified
immunological products, whether or not obtained by means of biotechnological processes
Free
3002.20.00 25 No† - Vaccines for human medicine Free 3002.30.00 27 .. - Vaccines for veterinary medicine Free 3002.90.00 - Other Free 10 kg Saxitoxin (CAS 35523-89-8) and salts thereof 11 kg Ricin (CAS 9009-86-3) and derivatives thereof 19 .. Other
3003 MEDICAMENTS (EXCLUDING GOODS OF 3002,
3005 OR 3006) CONSISTING OF TWO OR MORE CONSTITUENTS WHICH HAVE BEEN MIXED TOGETHER FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE:
3003.10.00 40 .. - Containing penicillins or derivatives thereof, with a
penicillanic acid structure, or streptomycins or their derivatives
Free
3003.20.00 42 .. - Containing other antibiotics Free
† No. of doses
# Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free.
Section 6
CUSTOMS TARIFF SCHEDULE 3
Chapter 30/4 Reference Number
Statistical Code/Unit Goods Rate #
3003.3 - Containing hormones or other products of 2937 but
not containing antibiotics:
3003.31.00 44 IU - - Containing insulin Free
3003.39.00 46 .. - - Other Free
3003.40.00 48 .. - Containing alkaloids or derivatives thereof but not containing hormones or other products of 2937 or antibiotics
Free
3003.90.00 49 .. - Other Free
3004 MEDICAMENTS (EXCLUDING GOODS OF 3002,
3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (INCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS FOR RETAIL SALE:
3004.10.00 50 .. - Containing penicillins or derivatives thereof, with a
penicillanic acid structure, or streptomycins or their derivatives
Free
3004.20.00 52 .. - Containing other antibiotics Free
3004.3 - Containing hormones or other products of 2937 but
not containing antibiotics:
3004.31.00 54 IU - - Containing insulin Free
� 3004.32.00 56 .. - - Containing adrenal corticosteroid hormones, their derivatives or structural analogues
Free
3004.39.00 58 .. - - Other Free
3004.40.00 59 .. - Containing alkaloids or derivatives thereof but not
containing hormones, other products of 2937 or antibiotics
3004.50.00 61 .. - Other medicaments containing vitamins or other
products of 2936
Free Free
3004.90.00 63 .. - Other Free
# Unless otherwise indicated NZ, PG, FI, DC, LDC and SG rates are Free. � Operative 1/1/07 Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free. Unless indicated in Schedule 6, rates for TH originating goods are Free. DCS denotes the rate for countries and places listed in Part 4 of Schedule 1 to this Act. DCT denotes the rate for HK, KR, SG and TW. If no DCT rate shown, DCS rate applies. If no DCT or DCS rate shown, general rate applies.
CUSTOMS TARIFF SCHEDULE 3
Section 6
R.4 Chapter 30/5 Reference Number
Statistical Code/Unit Goods Rate #
3005 WADDING, GAUZE, BANDAGES AND SIMILAR
ARTICLES (FOR EXAMPLE, DRESSINGS, ADHESIVE PLASTERS, POULTICES), IMPREGNATED OR COATED WITH PHARMACEUTICAL SUBSTANCES OR PUT UP IN FORMS OR PACKINGS FOR RETAIL SALE FOR MEDICAL, SURGICAL, DENTAL OR VETERINARY PURPOSES:
3005.10.00 01 .. - Adhesive dressings and other articles having an
adhesive layer
3005.90 - Other:
3005.90.10 02 .. - - - Wadding, including cotton wool and absorbent cotton
5% DCS:Free CA:Free 5%
3005.90.90 03 .. - - - Other 5%
DCS:Free CA:Free
# Unless otherwise indicated NZ, PG, FI, DC, LDC and SG rates are Free. 1/1/07 Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free. Unless indicated in Schedule 6, rates for TH originating goods are Free. DCS denotes the rate for countries and places listed in Part 4 of Schedule 1 to this Act. DCT denotes the rate for HK, KR, SG and TW. If no DCT rate shown, DCS rate applies. If no DCT or DCS rate shown, general rate applies.
Section 6
CUSTOMS TARIFF SCHEDULE 3
Chapter 30/6 Reference Number
Statistical Code/Unit Goods Rate #
3006
PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER:
� 3006.10 - Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or dental adhesion barriers, whether or not absorbable:
� 3006.10.1 - - - Sterile surgical or dental adhesion barriers, whether or not absorbable, of plastics:
� 3006.10.11 01 kg - - - - Of polymers of vinyl chloride, containing by weight not less than 6% of plasticisers, in the forms described in 3920
5% CA:Free
� 3006.10.12 02 kg - - - - Of plastics, in the forms described in 3920, as follows: (a) of polymers of ethylene; (b) of polymers of styrene; (c) of polymers of vinyl chloride, NSA; (d) of poly(vinyl butyral); (e) of polymides
5% CA:Free
� 3006.10.13 03 kg - - - - Of plastics, in the forms described in 3920, as follows: (a) of cellulose or its chemical derivaties; (b) of amino-resins; (c) of phenolic resins
Free
� 3006.10.14 04 kg - - - - Of plastics, in the forms described in 3921, as follows: (a) of polymers of styrene; (b) of vinyl chloride; (c) of polyurethanes
5% CA:Free
� 3006.10.15 05 kg - - - - Of cellulose or its chemical derivaties, coated, covered or laminated, NSA
Free
� 3006.10.19 06 kg - - - - Of other plastics 5% � 3006.10.2 - - - Sterile surgical or dental adhesion barriers,
whether or not absorbable, of textile fabrics:
� 3006.10.21 07 kg - - - - In the form of knitted or crocheted fabrics containing by weight 5% or more of elastomeric yarn or rubber thread
7.5% DC:2.5% CA:Free
From 1 January 2010 5% CA:Free
� 3006.10.22 08 kg - - - - Of other knitted or crocheted fabrics of a width not exceeding 30 cm
7.5% DC:2.5%
From 1 January 2010 5% � 3006.10.29 09 kg - - - - Of other knitted or crocheted fabrics 10%
DC:5% From 1 January 2010 5%
� 3006.10.90 10 .. - - - Other Free
# Unless otherwise indicated NZ, PG, FI, DC, LDC and SG rates are Free. � Operative 1/1/07 Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free. Unless indicated in Schedule 6, rates for TH originating goods are Free. DCS denotes the rate for countries and places listed in Part 4 of Schedule 1 to this Act. DCT denotes the rate for HK, KR, SG and TW. If no DCT rate shown, DCS rate applies. If no DCT or DCS rate shown, general rate applies.
3006.20.00
07 ..
- Blood-grouping reagents
Free
3006.30.00 09 .. - Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
Free
3006.40.00 10 ..
- Dental cements and other dental fillings; bone reconstruction cements
5%
3006.50.00 25 No - First-aid boxes and kits Free 3006.60.00 26 .. - Chemical contraceptive preparations based on
hormones, on other products of 2937 or on spermicides
Free
3006.70.00
- Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments
5%
40 .. Human medicine 42 .. Veterinary medicine
� 3006.9 - Other:
� 3006.91.00 01 .. - - Appliances identifiable for ostomy use 5% CA:Free
� 3006.92 - - Waste pharmaceuticals: � 3006.92.10 02 .. - - - Goods, as follows:
(a) of goods of 3005.90.10; (b) of goods of 3006.40.00
5%
� 3006.92.20 03 .. - - - Of goods of 3005, NSA 5% DCS:Free CA:Free
� 3006.92.30 07 .. - - - Of goods of Chapter 30, NSA Free � 3006.92.90 05 .. - - - Other 5%
25
# Unless otherwise indicated NZ, PG, FI, DC, LDC and SG rates are Free. � Operative 1/1/07 Unless otherwise indicated general rate applies for CA. Unless indicated in Schedule 5, rates for US originating goods are Free. Unless indicated in Schedule 6, rates for TH originating goods are Free. DCS denotes the rate for countries and places listed in Part 4 of Schedule 1 to this Act. DCT denotes the rate for HK, KR, SG and TW. If no DCT rate shown, DCS rate applies. If no DCT or DCS rate shown, general rate applies.
26
Apéndice II - Importaciones Australianas 2009
HTISC HTISC - Etiquetas Origen
AUS$ U$S
3001200007
Extracts of glands or other organs or of their
secretions Argentina
71,171.21 62,630.66
3001200007
Extracts of glands or other organs or of their
secretions Canada
350,650.00 308,572.00
3001200007
Extracts of glands or other organs or of their
secretions Denmark
1,709.40 1,504.27
3001200007
Extracts of glands or other organs or of their
secretions Taiwan
1,606.75 1,413.94
3001200007
Extracts of glands or other organs or of their
secretions
United Kingdom 1,177,864.24 1,036,520.53
3001200007
Extracts of glands or other organs or of their
secretions
United States of America
345,834.81 304,334.63
3001900005
Glands and other organs, dried, whether or not
powdered Nepal
3,283.06 2,889.09
3001900005
Glands and other organs, dried, whether or not
powdered New Zealand
87,689.20 77,166.50
3001900005
Glands and other organs, dried, whether or not
powdered
United States of America
11,704.06 10,299.57
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Australia (Re-imports)
2,000.00 1,760.00
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Austria
100,630.48 88,554.82
27
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
China
25,934.55 22,822.40
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Denmark
3,903.07 3,434.70
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
France
424,187.06 373,284.61
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Germany
58,406.12 51,397.39
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Ireland
2,854.47 2,511.93
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Israel
1,089.66 958.90
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
Netherlands
1,142,042.37 1,004,997.29
28
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
New Zealand
287,083.52 252,633.50
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
United Kingdom
1,060,500.34 933,240.30
3001900008
Herapin, its salts & human or animal substances
(excl. dried glands & other organs, extracts of glands or other organs or of their secretions, blood & blood
fractions & waste products) prepared for th
United States of America
2,550,609.66 2,244,536.50
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Albania
1,486.99 1,308.55
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Australia (Re-imports)
518,310.88 456,113.57
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Austria
72,343,196.58 63,662,012.99
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Belgium
12,549.69 11,043.73
29
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Brazil
6,347.59 5,585.88
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Canada
112,804.34 99,267.82
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Chile
2,190.10 1,927.29
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
China
20,032.75 17,628.82
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Czech Republic
10,004.23 8,803.72
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Denmark
5,819,825.42 5,121,446.37
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Finland
121,584.66 106,994.50
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
France
435,653.98 383,375.50
30
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Germany
37,530,615.07 33,026,941.26
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Hong Kong (SAR of China)
3,525,180.92 3,102,159.21
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Indonesia
2,180.86 1,919.16
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Ireland
11,157,007.74 9,818,166.81
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Israel
106,241.98 93,492.94
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Italy
2,763,440.89 2,431,827.98
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Japan
1,231,419.37 1,083,649.05
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Korea, Republic of
5,032.00 4,428.16
31
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Malaysia
1,028,342.84 904,941.70
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Netherlands
26,716,209.37 23,510,264.25
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
New Zealand
12,361,452.33 10,878,078.05
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Norway
103,229.70 90,842.14
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Puerto Rico
2,020,915.05 1,778,405.24
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Singapore
903,009.23 794,648.12
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Slovak Republic
6,292.89 5,537.74
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
South Africa
223,003.02 196,242.66
32
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Spain
3,635,504.38 3,199,243.85
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Sweden
35,645.34 31,367.90
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Switzerland
145,798,439.77 128,302,627.00
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
Taiwan
3,735,268.05 3,287,035.88
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
United Kingdom
60,301,459.43 53,065,284.30
3002100023
Antisera and other blood fractions and modified
immunological products, whether or not obtained
by means of biotechnological
processes
United States of America
65,064,635.12 57,256,878.91
3002200025 Vaccines for human
medicine Australia (Re-
imports) 717,182.41 631,120.52
3002200025 Vaccines for human
medicine Belgium 111,622,104.04 98,227,451.56
3002200025 Vaccines for human
medicine Canada 5,589,136.24 4,918,439.89
3002200025 Vaccines for human
medicine China 467,930.00 411,778.40
3002200025 Vaccines for human
medicine Denmark 5,521,059.09 4,858,532.00
3002200025 Vaccines for human
medicine France 25,104,091.30 22,091,600.34 3002200025 Vaccines for human Germany 1,918,729.57 1,688,482.02
33
medicine
3002200025 Vaccines for human
medicine Italy 8,094.81 7,123.43
3002200025 Vaccines for human
medicine Korea,
Republic of 1,894,542.04 1,667,197.00
3002200025 Vaccines for human
medicine Netherlands 28,528,442.89 25,105,029.74
3002200025 Vaccines for human
medicine New Zealand 182,651.91 160,733.68
3002200025 Vaccines for human
medicine Singapore 993,738.65 874,490.01
3002200025 Vaccines for human
medicine South Africa 10,108.81 8,895.75
3002200025 Vaccines for human
medicine Sweden 2,483,757.67 2,185,706.75
3002200025 Vaccines for human
medicine Switzerland 3,928,480.46 3,457,062.80
3002200025 Vaccines for human
medicine United
Kingdom 821,402.77 722,834.44
3002200025
Vaccines for human medicine
United States of America
158,895,446.06 139,827,992.53
3002300027 Vaccines for veterinary
medicine Australia (Re-
imports) 585,757.46 515,466.56
3002300027 Vaccines for veterinary
medicine Japan 1,245.33 1,095.89
3002300027 Vaccines for veterinary
medicine Netherlands 5,404,410.62 4,755,881.35
3002300027 Vaccines for veterinary
medicine New Zealand 1,990,019.60 1,751,217.25
3002300027 Vaccines for veterinary
medicine Spain 2,406,606.02 2,117,813.30
3002300027 Vaccines for veterinary
medicine United
Kingdom 248,100.34 218,328.30
3002300027
Vaccines for veterinary medicine
United States of America
16,500,470.30 14,520,413.86
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Australia (Re-imports)
71,046.66 62,521.06
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
Austria
95,600.86 84,128.76
34
saxitoxin (CAS 35523-89-8) and salts thereo
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Belgium
1,847.62 1,625.91
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Canada
970,659.37 854,180.25
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Chile
5,134.58 4,518.43
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
China
64,248.09 56,538.32
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Denmark
7,628,727.62 6,713,280.31
35
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Finland
252,847.05 222,505.40
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
France
2,474,099.82 2,177,207.84
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Germany
2,867,207.34 2,523,142.46
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
India
35,624.39 31,349.46
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Ireland
34,071,011.99 29,982,490.55
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Israel
42,495.54 37,396.08
36
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Italy
480,677.50 422,996.20
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Japan
8,639.20 7,602.50
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Malaysia
112,934.34 99,382.22
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Netherlands
194,127.60 170,832.29
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
New Zealand
278,567.13 245,139.07
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Papua New Guinea
1,168.06 1,027.89
37
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Spain
10,493.64 9,234.40
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Sweden
613,314.09 539,716.40
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
Switzerland
10,612,454.33 9,338,959.81
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
United Kingdom
7,075,823.08 6,226,724.31
3002900019
Human blood; animal blood prepared for
therapeutic, prophylactic or diagnostic uses, toxins,
cultures of micro-organisms and similar products (excl. yeasts,
saxitoxin (CAS 35523-89-8) and salts thereo
United States of America
12,075,268.38 10,626,236.17
3003100040
Medicaments (excl. HS 3002, 3005 & 3006) with two or more constituents mixed, for therapeutic or
prophylactic use & containing penicillins or streptomycins or their
derivatives, not put up in measured
China
319,054.56 280,768.01
38
3003100040
Medicaments (excl. HS 3002, 3005 & 3006) with two or more constituents mixed, for therapeutic or
prophylactic use & containing penicillins or streptomycins or their
derivatives, not put up in measured
Mexico
42,824.68 37,685.72
3003100040
Medicaments (excl. HS 3002, 3005 & 3006) with two or more constituents mixed, for therapeutic or
prophylactic use & containing penicillins or streptomycins or their
derivatives, not put up in measured
Turkey
279,954.20 246,359.70
3003100040
Medicaments (excl. HS 3002, 3005 & 3006) with two or more constituents mixed, for therapeutic or
prophylactic use & containing penicillins or streptomycins or their
derivatives, not put up in measured
United States of America
945,014.05 831,612.36
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
Hungary
24,933.21 21,941.22
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
India
562,977.05 495,419.80
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
Macau (SAR of China)
2,637,584.18 2,321,074.08
39
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
New Zealand
533,323.10 469,324.33
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
Puerto Rico
426,004.20 374,883.70
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
Spain
461,484.62 406,106.47
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
United Kingdom
32,811.44 28,874.07
3003200042
Medicaments with two or more constituents mixed,
for therapeutic or prophylactic use &
containing antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or their derivatives) not put up
United States of America
329,859.39 290,276.26
3003390046
Medicaments consist of two or more constituents,
for therapeutic or prophylactic use & contain hormones or products of
2937 (excl. HS 3002, 3005 & 3006 & insulin) not contain antibiotics, not put
up i
China
9,018.19 7,936.01
40
3003390046
Medicaments consist of two or more constituents,
for therapeutic or prophylactic use & contain hormones or products of
2937 (excl. HS 3002, 3005 & 3006 & insulin) not contain antibiotics, not put
up i
Ireland
3,618,619.36 3,184,385.04
3003390046
Medicaments consist of two or more constituents,
for therapeutic or prophylactic use & contain hormones or products of
2937 (excl. HS 3002, 3005 & 3006 & insulin) not contain antibiotics, not put
up i
Norway
3,870,988.68 3,406,470.04
3003390046
Medicaments consist of two or more constituents,
for therapeutic or prophylactic use & contain hormones or products of
2937 (excl. HS 3002, 3005 & 3006 & insulin) not contain antibiotics, not put
up i
United States of America
2,672.80 2,352.06
3003400048
Medicaments (excl. HS 3002, 3005 & 3006)
consist of two or more constituent, for therapeutic
or prophylactic use & contain alkaloids or derivs, not contain hormones, HS 2937 or antibiotics, not put
up
Czech Republic
19,747.03 17,377.39
3003400048
Medicaments (excl. HS 3002, 3005 & 3006)
consist of two or more constituent, for therapeutic
or prophylactic use & contain alkaloids or derivs, not contain hormones, HS 2937 or antibiotics, not put
up
United States of America
59,508.59 52,367.56
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Australia (Re-imports)
64,287.46 56,572.96
41
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Austria
1,102,920.88 970,570.37
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Belgium
46,730.98 41,123.26
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Brazil
333,382.67 293,376.75
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Canada
9,528,299.36 8,384,903.44
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
China
3,075,647.80 2,706,570.06
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Cyprus
284,400.67 250,272.59
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Czech Republic
65,143.75 57,326.50
42
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Denmark
53,477.67 47,060.35
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
France
818,983.60 720,705.57
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Germany
1,447,406.24 1,273,717.49
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Hungary
161,823.31 142,404.51
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Iceland
232,281.04 204,407.32
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
India
990,206.99 871,382.15
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Iran
168,750.00 148,500.00
43
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Ireland
23,892,960.89 21,025,805.58
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Israel
152,943.51 134,590.29
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Italy
768,690.37 676,447.53
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Japan
661,260.67 581,909.39
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Korea, Republic of
10,945.94 9,632.43
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Malta
112,361.11 98,877.78
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Netherlands
23,832.62 20,972.71
44
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
New Zealand
1,754,620.81 1,544,066.31
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Norway
77,033.92 67,789.85
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Portugal
30,282.87 26,648.93
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Samoa
1,137.39 1,000.90
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Singapore
1,567,860.14 1,379,716.92
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Slovak Republic
291,313.69 256,356.05
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
South Africa
1,194.00 1,050.72
45
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Spain
509,215.94 448,110.03
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Sweden
910,034.41 800,830.28
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
Switzerland
29,794.95 26,219.56
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
United Kingdom
1,518,534.52 1,336,310.38
3003900049
Medicaments with two or more constituents, for
therapeutic or prophylactic use (excl.HS 3002, 3005 or 3006, those containing
penicillins, antibiotics, alkoloids, hormones or HS
2937 & derivs) not in m
United States of America
9,670,452.45 8,509,998.16
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Australia (Re-imports)
1,309.80 1,152.62
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their
Austria
4,741,099.00 4,172,167.12
46
derivs, in measured dose (incl. transde
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Belgium
24,218.39 21,312.18
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
France
3,404,652.71 2,996,094.38
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Germany
2,158,408.50 1,899,399.48
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
India
8,066,895.16 7,098,867.74
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Ireland
1,091,140.88 960,203.97
47
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Italy
2,341,940.33 2,060,907.49
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Netherlands
585,408.97 515,159.89
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
New Zealand
250,442.18 220,389.12
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Spain
842,753.08 741,622.71
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
Switzerland
166,434.31 146,462.19
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
United Kingdom
18,332,350.93 16,132,468.82
48
3004100050
Medicaments (excl. HS 3002, 3005 or 3006) consist of mixed or unmixed goods, for
therapeutic or prophylactic use, containing penicillins,
streptomycins or their derivs, in measured dose
(incl. transde
United States of America
405,578.39 356,908.98
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Australia (Re-imports)
209,710.30 184,545.06
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Austria
5,333,401.75 4,693,393.54
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Belgium
5,817,567.63 5,119,459.51
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Brazil
1,665,127.06 1,465,311.81
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Canada
811,191.09 713,848.16
49
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
China
460,138.62 404,921.99
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Colombia
508,588.67 447,558.03
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Denmark
2,326,384.47 2,047,218.33
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
France
35,575,413.27 31,306,363.68
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Germany
14,479,059.42 12,741,572.29
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Hungary
12,394.36 10,907.04
50
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
India
9,408,746.35 8,279,696.79
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Iran
206,368.36 181,604.16
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Ireland
6,025,802.05 5,302,705.80
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Italy
20,139,792.23 17,723,017.16
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Japan
21,474,243.96 18,897,334.68
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Netherlands
1,097,186.76 965,524.35
51
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
New Zealand
1,698,551.66 1,494,725.46
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Norway
1,520,930.47 1,338,418.81
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Philippines
239,499.32 210,759.40
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Puerto Rico
159,624.97 140,469.97
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Romania
66,466.13 58,490.19
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Saudi Arabia
12,622.80 11,108.06
52
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Sierra Leone
59,041.24 51,956.29
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Singapore
2,956,561.60 2,601,774.21
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Slovenia
1,445,392.90 1,271,945.75
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
South Africa
6,015.22 5,293.39
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Spain
9,403,635.17 8,275,198.95
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Sweden
6,194,228.38 5,450,920.97
53
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Switzerland
3,880,619.86 3,414,945.48
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
Turkey
769,765.34 677,393.50
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
United Kingdom
8,199,090.28 7,215,199.45
3004200052
Medicaments of mixed or unmixed goods, for
therapeutic or prophylactic use, contain antibiotics (excl. HS 3002, 3005 &
3006, penicillins or streptomycins or derivs) in measured dose (incl. for
transde
United States of America
141,932,682.36 124,900,760.48
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
Canada
4,848.33 4,266.53
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
Denmark
42,614,600.25 37,500,848.22
54
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
France
37,626,209.44 33,111,064.31
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
Germany
20,995,615.30 18,476,141.46
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
Netherlands
1,041,383.62 916,417.59
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
United Kingdom
75,707.95 66,623.00
3004310054
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic uses & containing insulin but not containing antibiotics, in
measured doses (incl. for transdermal
United States of America
1,803,890.18 1,587,423.36
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Austria
82,742.98 72,813.82
55
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Belgium
18,736,496.62 16,488,117.03
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Finland
118,647.15 104,409.49
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
France
3,353,554.58 2,951,128.03
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Germany
5,348,324.67 4,706,525.71
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
India
1,995,676.77 1,756,195.56
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Ireland
261,100.83 229,768.73
56
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Israel
25,106.99 22,094.15
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Italy
325,318.16 286,279.98
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Netherlands
2,040.42 1,795.57
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Singapore
201,140.93 177,004.02
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Sweden
53,094,206.64 46,722,901.84
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
Switzerland
1,334.78 1,174.61
57
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
United Kingdom
97,192.02 85,528.98
3004320056
Medicaments (excl. HS 3002, 3005 & 3006) mixed
or unmixed, for therapeutic or prophylactic
use & contain corticosteroid hormone or
deriv or structural analogues but not contain
antibiotic, in measured
United States of America
1,998,461.57 1,758,646.18
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Australia (Re-imports)
12,724.48 11,197.54
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Austria
11,564,708.99 10,176,943.91
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Belgium
5,459,165.71 4,804,065.82
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Canada
183,904.02 161,835.54
58
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
China
2,781.90 2,448.07
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Denmark
13,869,816.67 12,205,438.67
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Fiji
939,185.06 826,482.85
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Finland
126,832.77 111,612.84
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
France
17,345,200.25 15,263,776.22
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Germany
22,209,255.00 19,544,144.40
59
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
India
163,194.06 143,610.77
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Ireland
35,476,564.14 31,219,376.44
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Italy
11,594,668.54 10,203,308.32
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Japan
14,083,772.36 12,393,719.68
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Netherlands
12,779,232.76 11,245,724.83
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
New Zealand
2,047,991.98 1,802,232.94
60
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Puerto Rico
256,218.63 225,472.39
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Singapore
19,201.24 16,897.09
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Spain
2,000.00 1,760.00
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Sweden
4,120,245.83 3,625,816.33
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
Switzerland
14,957,372.19 13,162,487.53
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
United Kingdom
39,297,022.42 34,581,379.73
61
3004390058
Medicaments, mixed or unmixed, for therapeutic
or prophylactic use & contain hormones or
goods of 2937 (excl. HS 3002, 3005 & 3006,
insulin & corticosteroid hormone & derivs) not
contain antibiotics,
United States of America
152,838,367.94 134,497,763.79
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Argentina
977,582.97 860,273.01
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Australia (Re-imports)
553,223.23 486,836.44
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Belgium
237,948.82 209,394.96
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Canada
121,907.19 107,278.33
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
China
5,367.91 4,723.76
62
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
France
3,350,249.15 2,948,219.25
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Germany
6,172,703.59 5,431,979.16
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Greece
20,702.12 18,217.87
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Hungary
320,544.11 282,078.82
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
India
7,316,133.70 6,438,197.66
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Italy
1,882,600.49 1,656,688.43
63
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Japan
26,467.72 23,291.59
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Netherlands
347,471.34 305,774.78
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
New Zealand
1,540,644.39 1,355,767.06
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Singapore
900,012.94 792,011.39
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Slovak Republic
612,476.94 538,979.71
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
South Africa
743,000.67 653,840.59
64
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Spain
890,718.86 783,832.60
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
Switzerland
44,990.39 39,591.54
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
United Kingdom
20,962,792.27 18,447,257.20
3004400059
Medicaments (excl. HS 3002, 3005 or 3006)
mixed or unmixed, for therapeutic or prophylactic use and contain alkaloids or derivs but not contain hormones or products of
2937 or antibiotics, in measured
United States of America
361,916.18 318,486.24
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Australia (Re-imports)
30,601.81 26,929.59
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Canada
13,738,429.59 12,089,818.04
65
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
China
1,256,405.84 1,105,637.14
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Denmark
2,799,402.55 2,463,474.24
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Finland
167,627.12 147,511.87
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
France
147,805.97 130,069.25
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Germany
6,461,858.55 5,686,435.52
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Hong Kong (SAR of China)
6,847.90 6,026.15
66
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
India
2,805,254.15 2,468,623.65
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Indonesia
12,447,406.27 10,953,717.52
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Italy
152,999.02 134,639.14
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Netherlands
1,285,979.89 1,131,662.30
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
New Zealand
18,077,303.14 15,908,026.76
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Norway
65,935.05 58,022.84
67
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Singapore
185,933.78 163,621.73
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
South Africa
1,295.09 1,139.68
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Spain
270,830.16 238,330.54
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Sweden
28,968.91 25,492.64
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
Switzerland
1,535,669.98 1,351,389.58
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
United Kingdom
9,464,624.47 8,328,869.53
68
3004500061
Medicaments (excl. HS 3002, 3005 or 3006) of
mixed or unmixed goods, for therapeutic or
prophylactic use, contain vitamins or products of
2936, in measured doses (incl. those of transdermal
administra
United States of America
4,522,299.45 3,979,623.52
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Argentina
1,158,354.08 1,019,351.59
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Australia (Re-imports)
5,400,325.36 4,752,286.32
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Austria
24,056,049.11 21,169,323.22
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Belgium
216,367,499.34 190,403,399.42
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Belize
4,507.53 3,966.63
69
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Brazil
930,869.22 819,164.91
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Canada
46,471,310.40 40,894,753.15
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
China
15,295,684.41 13,460,202.28
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Cyprus
1,856,908.82 1,634,079.76
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Czech Republic
1,293,791.12 1,138,536.19
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Denmark
49,739,692.68 43,770,929.56
70
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Fiji
1,290,554.06 1,135,687.57
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Finland
36,637,315.21 32,240,837.38
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
France
662,239,903.68 582,771,115.24
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
French Guiana
1,376.06 1,210.93
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Germany
690,271,684.26 607,439,082.15
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Greece
26,138,658.11 23,002,019.14
71
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Guinea
81,065.80 71,337.90
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Hong Kong (SAR of China)
1,320,727.38 1,162,240.09
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Hungary
435,423.36 383,172.56
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Iceland
310,570.81 273,302.31
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
India
58,418,753.20 51,408,502.82
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Indonesia
1,817,919.65 1,599,769.29
72
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Iran
614,657.57 540,898.66
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Ireland
854,208,437.14 751,703,424.68
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Israel
13,758,644.87 12,107,607.49
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Italy
357,254,912.31 314,384,322.83
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Japan
28,767,228.58 25,315,161.15
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Korea, Republic of
115,693.09 101,809.92
73
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Luxembourg
61,567.23 54,179.16
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Malaysia
918,056.22 807,889.47
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Malta
2,174,408.51 1,913,479.49
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Mexico
4,420,881.99 3,890,376.15
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Netherlands
136,642,273.63 120,245,200.79
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
New Zealand
34,139,881.90 30,043,096.07
74
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Norway
278,960.90 245,485.59
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Pakistan
1,115.93 982.02
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Philippines
6,336,213.81 5,575,868.15
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Poland
6,613,351.48 5,819,749.30
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Portugal
487,391.86 428,904.84
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Puerto Rico
277,895,896.36 244,548,388.80
75
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Romania
140,064.93 123,257.14
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Samoa (American)
51,824.77 45,605.80
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Singapore
157,702,135.88 138,777,879.57
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Slovak Republic
662,359.41 582,876.28
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Slovenia
558,506.18 491,485.44
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
South Africa
5,993,979.74 5,274,702.17
76
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Spain
522,308,059.03 459,631,091.95
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Sweden
308,484,406.05 271,466,277.32
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Switzerland
647,787,093.46 570,052,642.24
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Taiwan
257,130.66 226,274.98
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Tajikistan
2,032,463.90 1,788,568.23
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Thailand
1,191,012.57 1,048,091.06
77
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Tunisia
1,470.96 1,294.44
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Turkey
7,509,396.95 6,608,269.32
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
United Arab Emirates
11,476.80 10,099.58
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
United Kingdom
760,116,858.52 668,902,835.50
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
United States of America
574,392,260.50 505,465,189.24
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or HS 2937, alkaloids or
derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Viet Nam
3,736.96 3,288.52
78
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Australia (Re-imports)
3,333.05 2,933.08
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Belgium
647,774.28 570,041.37
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Brazil
566,292.28 498,337.21
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Canada
19,076.95 16,787.72
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
China
3,363,511.46 2,959,890.08
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Colombia
51,928.70 45,697.26
79
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Denmark
1,092,578.45 961,469.04
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Egypt
402,294.12 354,018.83
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Finland
5,587,422.05 4,916,931.40
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
France
1,363,183.75 1,199,601.70
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Germany
2,996,486.10 2,636,907.77
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Hong Kong (SAR of China)
191,144.38 168,207.05
80
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Hungary
2,436,062.18 2,143,734.72
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
India
980,515.80 862,853.90
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Indonesia
4,702.08 4,137.83
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Israel
12,576.06 11,066.93
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Italy
164,224.91 144,517.92
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Japan
2,907,811.11 2,558,873.78
81
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Korea, Republic of
383,604.56 337,572.01
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Macau (SAR of China)
1,876.56 1,651.37
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Malaysia
372,372.01 327,687.37
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Mexico
1,009,563.47 888,415.85
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Netherlands
2,864,896.11 2,521,108.58
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
New Zealand
62,382.73 54,896.80
82
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Singapore
21,073.72 18,544.87
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Slovak Republic
1,651,675.20 1,453,474.18
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
South Africa
1,597,563.40 1,405,855.79
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Spain
5,157,721.92 4,538,795.29
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Sweden
20,658.70 18,179.66
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Switzerland
90,739.18 79,850.48
83
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Taiwan
49,725.37 43,758.33
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Thailand
5,251,144.73 4,621,007.36
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Turkey
5,580.37 4,910.73
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
United Kingdom
6,152,129.74 5,413,874.17
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
United States of America
13,149,804.16 11,571,827.66
3005100001
Adhesive dressings & other articles having an
adhesive layer, impregnated or coated
with pharmaceutical substances or put up in
forms or packings for retail sale for medical, surgical,
dental or veter
Viet Nam
6,772.08 5,959.43
84
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Belgium
9,782.26 8,608.39
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Canada
1,382.06 1,216.21
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
China
695,318.66 611,880.42
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Finland
274,941.51 241,948.53
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
France
17,035.58 14,991.31
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Germany
165,220.03 145,393.63
85
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Italy
11,204.16 9,859.66
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Japan
10,631.53 9,355.75
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Malaysia
131,917.50 116,087.40
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Mexico
56,532.15 49,748.29
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
New Zealand
842,500.15 741,400.13
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Switzerland
33,925.09 29,854.08
86
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Taiwan
14,584.65 12,834.49
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
Turkey
131,796.04 115,980.52
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
United Kingdom
78,140.99 68,764.07
3005901002
Wadding (incl. cotton wool and absorbent cotton) impregnated or coated
with pharmaceutical substances or for retail
sale for medical, surgical, dental or vet purposes (excl. adhesive & waste
products)
United States of America
1,871,637.59 1,647,041.08
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Australia (Re-imports)
30,677.70 26,996.38
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Austria
11,168.62 9,828.39
87
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Belgium
1,751,332.21 1,541,172.34
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Bosnia and Herzegovina
85,425.23 75,174.20
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Canada
8,127,140.84 7,151,883.94
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
China
18,978,044.76 16,700,679.39
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Czech Republic
12,413.43 10,923.82
88
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Denmark
790,772.16 695,879.50
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Dominican Republic
18,950.40 16,676.35
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Egypt
79,034.26 69,550.15
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Finland
24,277.38 21,364.09
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Former Yug Rep
Macedonia
24,886.88 21,900.45
89
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
France
688,644.75 606,007.38
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Germany
4,126,932.04 3,631,700.20
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Hong Kong (SAR of China)
23,246.93 20,457.30
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Hungary
1,308.67 1,151.63
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
India
1,678,445.71 1,477,032.22
90
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Indonesia
29,883.77 26,297.72
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Ireland
8,826.11 7,766.98
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Israel
38,695.99 34,052.47
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Italy
1,231,591.83 1,083,800.81
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Japan
601,413.99 529,244.31
91
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Korea, Dem People's Rep
1,855.00 1,632.40
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Korea, Republic of
129,581.23 114,031.48
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Malaysia
2,712,088.29 2,386,637.70
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Mexico
1,802,504.45 1,586,203.92
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Netherlands
8,214,154.45 7,228,455.92
92
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
New Zealand
273,439.24 240,626.53
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Pakistan
11,050.81 9,724.71
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Philippines
2,929.22 2,577.71
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Poland
233,080.49 205,110.83
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Puerto Rico
30,047.32 26,441.64
93
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Russian Federation
1,898.27 1,670.48
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Singapore
28,161.85 24,782.43
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
South Africa
85,492.08 75,233.03
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Sweden
167,016.74 146,974.73
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Switzerland
14,619.88 12,865.49
94
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Syria
4,601.78 4,049.57
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Taiwan
4,782,083.26 4,208,233.27
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
Thailand
407,738.30 358,809.70
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
United Kingdom
9,986,518.69 8,788,136.45
3005909003
Gauze, bandages & articles such as dressings
& poultices (excl. adhesive dressings,
wadding & waste products) impregnated or
coated with pharmaceutical
substances or for retail sale for medical, surgi
United States of America
8,403,400.79 7,394,992.70
3006101202
Sterile surgical & dental adhesion barriers, of
plates, sheets, film, foil & strip of polymers of
ethylene & styrene, PVC, polyvinyl butyral &
Malaysia
186,782.10 164,368.25
95
polyamides. For details, please see Tariff.
3006101303
Sterile surgical & dental adhesion barriers, of
plates, sheets, film, foil and strip of cellulose & deriv., amino-resins, phenolic resins, non-
cellular & not reinforced, lamin, supported or
combined w
United States of America
53,866.30 47,402.34
3006101906
Sterile surgical or dental adhesion barriers,
whether or not absorbable, of plastics, nes. For details, please
see Tariff.
Canada
35,368.00 31,123.84
3006101906
Sterile surgical or dental adhesion barriers,
whether or not absorbable, of plastics, nes. For details, please
see Tariff.
Italy
34,544.52 30,399.18
3006101906
Sterile surgical or dental adhesion barriers,
whether or not absorbable, of plastics, nes. For details, please
see Tariff.
Switzerland
1,928.43 1,697.02
3006101906
Sterile surgical or dental adhesion barriers,
whether or not absorbable, of plastics, nes. For details, please
see Tariff.
United States of America
634,451.59 558,317.40
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Austria
716,152.59 630,214.28
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
Belgium
7,458,663.58 6,563,623.95
96
or dental
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Brazil
10,584.96 9,314.76
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
China
612,924.76 539,373.79
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Denmark
531,398.16 467,630.38
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Dominican Republic
474,748.36 417,778.56
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
France
620,435.58 545,983.31
97
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Germany
1,158,345.36 1,019,343.92
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Hungary
2,743.18 2,414.00
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Iceland
1,352.92 1,190.57
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Ireland
5,328.27 4,688.88
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Israel
84,000.00 73,920.00
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Italy
94,471.91 83,135.28
98
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Japan
5,887.86 5,181.32
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Korea, Republic of
943,003.99 829,843.51
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Malaysia
831,713.29 731,907.70
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Mexico
190,998.75 168,078.90
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Netherlands
37,068.06 32,619.89
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
New Zealand
22,709.92 19,984.73
99
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Norway
4,559.82 4,012.64
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Pakistan
2,514.22 2,212.51
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Portugal
2,467.83 2,171.69
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Singapore
12,501.21 11,001.06
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Spain
1,127,481.78 992,183.97
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
Switzerland
747,925.26 658,174.23
100
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
United Kingdom
1,875,285.03 1,650,250.83
3006109010
Sterile surgical catgut, similar sterile suture materials and sterile tissue adhesives for
surgical wound closure; sterile laminaria and
sterile laminaria tents; sterile absorbable surgical
or dental
United States of America
57,040,529.08 50,195,665.59 3006200007 Blood-grouping reagents Canada 1,016.77 894.76 3006200007 Blood-grouping reagents Germany 11,645.17 10,247.75 3006200007 Blood-grouping reagents Italy 13,906.66 12,237.86 3006200007 Blood-grouping reagents Switzerland 2,262,239.24 1,990,770.53
3006200007 Blood-grouping reagents United
Kingdom 207,617.84 182,703.70
3006200007 Blood-grouping reagents United States
of America 2,625,961.11 2,310,845.78
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Brazil
7,703.74 6,779.29
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Canada
4,064,121.05 3,576,426.52
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
China
4,874,583.27 4,289,633.28
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Finland
108,802.24 95,745.97
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
France
436,198.89 383,855.02
101
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Germany
8,014,489.96 7,052,751.16
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Hong Kong (SAR of China)
38,863.36 34,199.76
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
India
1,934.29 1,702.18
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Ireland
1,424,386.32 1,253,459.96
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Italy
5,348,759.56 4,706,908.41
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Netherlands
222,158.79 195,499.74
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Norway
1,217,988.95 1,071,830.28
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Spain
1,197,329.91 1,053,650.32
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Sweden
1,441.64 1,268.64
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
United Kingdom
361,905.46 318,476.80
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
United States of America
4,438,498.31 3,905,878.51
102
3006300009
Opacifying preparations for X-ray examinations;
diagnostic reagents designed to be
administered to the patient
Vanuatu
9,860.96 8,677.64
3006400010
Dental cements and other dental fillings; bone
reconstruction cements
Australia (Re-imports) 143,451.53 126,237.35
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Austria
1,216.75 1,070.74
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Belgium
238,936.06 210,263.73
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Belize
1,795.83 1,580.33
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Brazil
13,869.01 12,204.73
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Canada
2,311.60 2,034.21
3006400010
Dental cements and other dental fillings; bone
reconstruction cements China
8,339.45 7,338.72
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Denmark
18,515.80 16,293.90
3006400010
Dental cements and other dental fillings; bone
reconstruction cements France
99,182.15 87,280.29
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Germany
7,598,384.98 6,686,578.78
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Greece
8,441.72 7,428.71
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Ireland
8,127,348.35 7,152,066.55
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Italy
50,392.36 44,345.28
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Japan
5,633,264.52 4,957,272.78
3006400010
Dental cements and other dental fillings; bone
reconstruction cements
Korea, Republic of 81,760.95 71,949.64
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Mexico
41,598.19 36,606.41
3006400010 Dental cements and other
dental fillings; bone New Zealand 6,098.10 5,366.33
103
reconstruction cements
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Singapore
5,735,522.09 5,047,259.44
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Sweden
281,980.05 248,142.44
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Switzerland
2,267,798.23 1,995,662.44
3006400010
Dental cements and other dental fillings; bone
reconstruction cements
United Kingdom 3,169,697.13 2,789,333.47
3006400010
Dental cements and other dental fillings; bone
reconstruction cements
United States of America
4,757,099.00 4,186,247.12
3006400010
Dental cements and other dental fillings; bone
reconstruction cements Viet Nam
12,091.57 10,640.58
3006500025 First-aid boxes and kits Australia (Re-
imports) 44,108.66 38,815.62 3006500025 First-aid boxes and kits Belgium 5,983.28 5,265.29 3006500025 First-aid boxes and kits Canada 8,928.21 7,856.82 3006500025 First-aid boxes and kits China 2,408,294.52 2,119,299.18 3006500025 First-aid boxes and kits Egypt 36,146.40 31,808.83 3006500025 First-aid boxes and kits France 1,165.61 1,025.74 3006500025 First-aid boxes and kits Germany 2,987.22 2,628.75
3006500025 First-aid boxes and kits
Hong Kong (SAR of China) 50,444.34 44,391.02
3006500025 First-aid boxes and kits India 19,713.88 17,348.21 3006500025 First-aid boxes and kits Italy 41,584.55 36,594.40
3006500025 First-aid boxes and kits Korea,
Republic of 54,968.94 48,372.67
3006500025 First-aid boxes and kits New Zealand
44,165.39 38,865.54 3006500025 First-aid boxes and kits Philippines 22,187.71 19,525.18 3006500025 First-aid boxes and kits Singapore 10,089.31 8,878.59 3006500025 First-aid boxes and kits Sweden 1,226.90 1,079.67 3006500025 First-aid boxes and kits Switzerland 45,923.16 40,412.38 3006500025 First-aid boxes and kits Taiwan 6,175.45 5,434.40
3006500025 First-aid boxes and kits United
Kingdom 63,485.12 55,866.91
3006500025 First-aid boxes and kits United States
of America 140,185.14 123,362.92
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
Belgium
104,069.84 91,581.46
104
spermicides
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
Fiji
159,877.52 140,692.22
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
Germany
39,861,632.54 35,078,236.64
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
Hungary
1,565,771.98 1,377,879.34
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
Ireland
3,430,476.35 3,018,819.19
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
Netherlands
11,148,015.84 9,810,253.94
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
New Zealand
15,252.57 13,422.26
3006600026
Chemical contraceptive preparations based on
hormones, on other products of 2937 or on
spermicides
United Kingdom
1,394,409.65 1,227,080.49
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Australia (Re-imports)
3,150.00 2,772.00
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
Canada
56,392.15 49,625.09
105
medical instrum
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
China
9,116.85 8,022.83
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Costa Rica
2,455.00 2,160.40
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Germany
33,758.86 29,707.80
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Iran
2,455.00 2,160.40
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Israel
2,736.66 2,408.26
106
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Italy
112,286.17 98,811.83
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Japan
8,045.00 7,079.60
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Malaysia
2,640.00 2,323.20
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Netherlands
4,653.40 4,094.99
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
New Zealand
39,584.62 34,834.47
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Switzerland
652,100.51 573,848.45
107
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Taiwan
29,093.35 25,602.15
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
Thailand
575,419.97 506,369.57
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
United Kingdom
213,307.38 187,710.49
3006700040
Gel preparations designed to be used in human
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical instrum
United States of America
1,021,513.87 898,932.21
3006700042
Gel preparations designed to be used in veterinary
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical in
France
3,927.00 3,455.76
3006700042
Gel preparations designed to be used in veterinary
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical in
Netherlands
1,723.86 1,517.00
108
3006700042
Gel preparations designed to be used in veterinary
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical in
New Zealand
3,805.90 3,349.19
3006700042
Gel preparations designed to be used in veterinary
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical in
United Kingdom
5,895.22 5,187.79
3006700042
Gel preparations designed to be used in veterinary
medicine as a lubricant for parts of the body for
surgical operations or physical examinations or
as a coupling agent between the body and
medical in
United States of America
32,902.76 28,954.43
3006910001 Appliances identifiable for
ostomy use Canada 1,147.37 1,009.69
3006910001 Appliances identifiable for
ostomy use China 14,114.84 12,421.06
3006910001 Appliances identifiable for
ostomy use Denmark 6,701,739.71 5,897,530.94
3006910001 Appliances identifiable for
ostomy use Dominican Republic 1,729,285.34 1,521,771.10
3006910001 Appliances identifiable for
ostomy use Germany 72,898.51 64,150.69
3006910001 Appliances identifiable for
ostomy use Hungary 975,668.90 858,588.63
3006910001 Appliances identifiable for
ostomy use Ireland 3,693,827.15 3,250,567.89
3006910001 Appliances identifiable for
ostomy use Japan 2,715.07 2,389.26
3006910001 Appliances identifiable for
ostomy use South Africa 1,101.25 969.10
3006910001 Appliances identifiable for
ostomy use Spain 35,651.60 31,373.41
3006910001 Appliances identifiable for
ostomy use Taiwan 217,052.44 191,006.15
3006910001 Appliances identifiable for
ostomy use United
Kingdom 2,409,133.73 2,120,037.68
3006910001
Appliances identifiable for ostomy use
United States of America
6,335,141.70 5,574,924.70
109
3006923007 Waste goods of Chapter
30, NSA Spain 76,764.04 67,552.36
3006923007 Waste goods of Chapter
30, NSA United
Kingdom 5,648.53 4,970.71
3006929005 Waste pharmaceuticals,
NSA China 2,787.82 2,453.28
3006929005 Waste pharmaceuticals,
NSA Germany 3,848.36 3,386.56
3006929005
Waste pharmaceuticals, NSA
United States of America
2,503.88 2,203.41 Fuente ABS – Australian Bureau of Statistics
8 - Apéndice III – Evolución y Participación de Argentina – 2009
HTISC HTISC - Etiquetas Origen AUS$ U$S
3001200007
Extracts of glands or other organs or of their
secretions Argentina
71,171.21 62,630.66
3004400059
Medicaments (excl. HS 3002, 3005 or 3006) mixed or unmixed, for therapeutic
or prophylactic use and contain alkaloids or derivs but not contain hormones
or products of 2937 or antibiotics, in measured
Argentina
977,582.97 860,273.01
3004900063
Medicaments for therapeutic or prophylactic use (excl. HS 3002, 3005,
3006, with penicillin, antibiotics, hormones or
HS 2937, alkaloids or derivs & vitamins or HS 2936) in measured dose
(incl. for tr
Argentina
1,158,354.08 1,019,351.59 Fuente ABS – Australian Bureau of Statistics CONSULADO GENERAL DE ARGENTINA en Sydney Level 20, 44 Market St, Sydney NSW 2000 PO Box Q1613, QVB Post Office NSW 1230 Tel: +61 2 9262 2933 - Fax: +61 2 9262 3998 [email protected]